Back
Day Range
$18.59
$19.56
52-Week Range
$17.15
$42.50
Volume
2,807,289
50D / 200D Avg
$21.91
/
$27.71
Prev Close
$18.41
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -10.1 | 0.4 |
| P/B | 9.4 | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | -66.3 | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.7 | 0.2 |
Analyst Price Target
Hold
$31.33
+62.7%
Low: $26.00
High: $38.00
Forward P/E
109.4
Forward EPS
$0.18
EPS Growth (est.)
+0.0%
Est. Revenue
1 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$1.16
$1.14 – $1.18
|
1.8 B | 2 |
| FY2029 |
$1.07
$1.05 – $1.09
|
1.7 B | 4 |
| FY2028 |
$0.71
$0.44 – $0.97
|
1.4 B | 6 |
Key Takeaways
Generating 66.90M in free cash flow
Capital efficient — spends only 2.00% of revenue on capex
ROIC of 3.54% — low return on invested capital
Interest coverage of 0.79× — tight debt servicing
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)96.97%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROIC3.54%
Net Margin-66.25%
Op. Margin5.56%
Safety
Debt / Equity
0.66
Current Ratio7.85
Interest Coverage0.79
Valuation
P/E Ratio
-10.12
P/B Ratio9.43
EV/EBITDA111.36
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 96.97% | Revenue Growth (3Y) | 62.87% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 812.03M | Net Income (TTM) | -537.96M |
| ROE | N/A | ROA | -47.79% |
| Gross Margin | 66.40% | Operating Margin | 5.56% |
| Net Margin | -66.25% | Free Cash Flow (TTM) | 66.90M |
| ROIC | 3.54% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.66 | Current Ratio | 7.85 |
| Interest Coverage | 0.79 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -10.12 | P/B Ratio | 9.43 |
| P/S Ratio | 6.70 | PEG Ratio | 2.83 |
| EV/EBITDA | 111.36 | Dividend Yield | 0.00% |
| Market Cap | 5.44B | Enterprise Value | 5.02B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 812.03M | 412.26M | 306.13M | 258.49M | 294.01M |
| Net Income | -537.96M | -281.89M | -341.42M | -320.83M | 27.73M |
| EPS (Diluted) | -1.90 | -2.70 | -1.82 | -1.57 | 1.55 |
| Gross Profit | 539.17M | 178.78M | 89.31M | 80.02M | 184.16M |
| Operating Income | 45.11M | -257.12M | -319.55M | -315.76M | 139.09M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 1.13B | 343.73M | 412.90M | 717.42M | 2.61B |
| Total Liabilities | 548.36M | 2.84B | 2.56B | 2.42B | 1.91B |
| Shareholders' Equity | 577.31M | -2.50B | -2.14B | -1.70B | 702.24M |
| Total Debt | 378.99M | 424.26M | 217.27M | 270.87M | 1.75B |
| Cash & Equivalents | 797.80M | 63.95M | 56.40M | 107.19M | 53.55M |
| Current Assets | 997.80M | 215.73M | 242.61M | 516.04M | 214.66M |
| Current Liabilities | 127.15M | 165.42M | 95.14M | 136.91M | 320.25M |